Nursing Role in Reproductive and Sexual Health – Study Notes

KEY TERMS

• adrenarche
• andrology
• anteflexion
• anteversion
• aspermia
• bicornuate uterus
• culdoscopy
• cystocele
• gonad
• gynecology
• gynecomastia
• laparoscopy
• menarche
• oocyte
• puberty
• rectocele
• retroflexion
• retroversion
• spermatic cord

OBJECTIVES

• Discuss Healthy People 2030 goals that nurses can help the nation achieve related to reproductive health.
• Formulate nursing diagnoses related to reproductive and sexual health.
• Develop expected outcomes for reproductive health education to manage seamless transitions across differing healthcare settings.
• Assess a couple for anatomic and physiologic health and readiness for childbearing.
• Assess a couple for reproductive planning and sexual health needs related to sexual orientation and gender identity if pertinent.
• Describe anatomy and physiology pertinent to reproductive and sexual health.
• Using the nursing process, plan nursing care that includes the six QSEN competencies: patient-centered care, teamwork and collaboration, evidence-based practice, quality improvement, safety, and informatics.
• Implement nursing care related to reproductive and sexual health (e.g., educating middle school children about menstruation).
• Evaluate expected outcomes for achievement and effectiveness of care.
• Integrate knowledge of preparation for childbearing with the nursing process, the six QSEN competencies, and family nursing to promote quality maternal and child health nursing care.

CASE CONTEXT AND COUNSELING GOALS

• S.M. and K.M., a young adult couple, planned to conceive; pregnancy achieved after about 1 year of trying.
• At 12 weeks gestation, S.M. reports relationship distress and fear about pregnancy from K.M.
• Nurse guidance emphasizes that reproductive anatomy/physiology and sexual health are relevant to all patients, regardless of planned pregnancy status.
• Encourage open dialogue about sexual health; CDC definition of sexual health as physical, emotional, and psychosocial well-being (CDC, 2019).
• Normalize questions about normalcy of sexual development, menstruation, contraception, and fertility.
• Box 5.1 highlights Healthy People 2030 goals related to reproductive and sexual health and the nurse’s role in achieving them.

BOX 5.1 BOX CONTENT: NURSING CARE PLANNING BASED ON HEALTHY PEOPLE 2030 GOALS

• Goals relevant to reproductive/sexual health include:
  • Increase adolescents aged 15–17 who have never had sexual intercourse to $80.8\%$ from a baseline of $76.7\%$.
  • Increase contraception use at last intercourse among sexually active 15–19-year-olds at risk for unintended pregnancy to $36.8\%$ from $24.1\%$.
  • Reduce breast cancer deaths to ≤ $15.3$ per 100,000 from $19.7$ per 100,000.
  • Improve health, safety, and well-being of LGBTQ+ individuals via development goals. (HP 2030)
• Nurse actions include: educate adolescents about abstinence, refusal skills, safer sex, HPV vaccination; teach vulvar and testicular self-examination; promote inclusive, nonjudgmental care.
• Emphasizes the need for safety, equity, and culturally competent care in reproductive/sexual health education.

NURSING PROCESS OVERVIEW FOR PROMOTION OF REPRODUCTIVE AND SEXUAL HEALTH

• Assessment challenges: problems may not be evident at first contact; ongoing follow-up and continuity of care are essential.
• Conditions needing assessment include: STI concerns, body image changes (puberty/pregnancy), high-risk sexual behaviors, alterations in reproductive organs, menopause, chronic fatigue or pain, spinal cord injury, and catheter-related issues.
• Common nursing diagnoses include:
  • Health-seeking behaviors related to reproductive functioning
  • Anxiety related to inability to conceive
  • Pain related to menstrual cramping
  • Altered body image related to early development of secondary sexual characteristics
  • Infection risk related to high-risk sexual behaviors
  • Sexual dysfunction/altered sexuality patterns related to illness or fear of harming a fetus
• Outcome identification and planning emphasizes patient empowerment, knowledge about reproductive anatomy/physiology, alleviation of discomfort, and acceptance of all sexual orientations and gender identities.
• Online resources include CDC, It Gets Better, Not 2 Late, Planned Parenthood, Sex & U: It’s a plan, ASRM, RESOLVE, AAKSIS, March of Dimes, and genome/hemet info.
• Implementation focuses on education as a primary nursing role, with inclusive communication about orientation, gender identity, and partner gender.
• Outcome evaluation requires ongoing assessment as pregnancy status, age, maturity, and psychosocial context change.

ASSESSING REPRODUCTIVE HEALTH CONCERNS

• Initial health interview should assess knowledge level about the reproductive process, STIs, safety, and safer sex practices.
• Box 5.2 emphasizes effective communication strategies:
  • Use specific, open-ended questions; remain nonjudgmental; adolescents may value privacy and honesty.
• During physical exams, observe for normal hair distribution, genital/breast development, and signs of STIs.
• Teaching strategies may include models, diagrams, videos, and in-person demonstrations; follow up to confirm understanding.
• Box 5.3 lists specific questions in a sexual history (e.g., sexual activity, partner gender, number of partners, safer sex practices, PrEP questions, STI history, erectile function concerns, contraception use, HPV vaccination).
• For all individuals aged 9–45, assess HPV vaccination status.

NURSING DIAGNOSES (REPRODUCTIVE HEALTH)

• Health-seeking behaviors related to reproductive functioning
• Anxiety related to inability to conceive after 6 months without contraception
• Pain related to uterine cramping during menses
• Altered body image related to puberty development
• Infection risk related to high-risk sexual behaviors
• Sexual function-related diagnoses (sexual dysfunction, altered sexuality patterns, low self-esteem related to reproduction or recent surgery, etc.)

OUTCOME IDENTIFICATION AND PLANNING (REPRODUCTIVE HEALTH)

• Key aim: empower patients to feel control over their bodies and health decisions.
• Plan health teaching about reproductive systems and methods to alleviate discomfort or prevent disease.
• Ensure care plans reflect acceptance of all sexual orientations and gender identities.
• Example outcomes:
  • Patient states they are taking precautions to prevent contracting an STI.
  • Couple reports achieving a mutually satisfying sexual relationship.
  • Patient states enhanced ability to manage premenstrual symptoms with education.

IMPLEMENTATION: REPRODUCTIVE AND SEXUAL HEALTH EDUCATION

• A primary role is education; patients may ask about contraception, fertility, STI prevention, and congenital health conditions.
• Ask patients about sexual orientation and gender identity to tailor safer sex and contraception counseling.
• Do not assume activity types; screen broadly (e.g., anal sex, multiple partners, condom use).
• Provide age-appropriate, developmentally appropriate information; use visuals/models; consider online resources for privacy.

OUTCOME EVALUATION

• Continuous evaluation as life stages transition (e.g., pregnancy progression, postpartum changes, adolescence).
• Examples of expected outcomes:
  • Patient uses preventive precautions to avoid STI transmission.
  • Couple maintains a mutually satisfying sexual relationship during pregnancy or transitions.
• Documentation should reflect patient education provided and understanding achieved.

BOX 5.2: NURSING CARE PLANNING TIPS FOR EFFECTIVE COMMUNICATION (SEXUAL HEALTH)

• When addressing delayed menarche or pubertal concerns, tailor questions to youths’ privacy and comfort level.
• Use open-ended prompts to encourage discussion and truthfulness.
• Example: adolescent patient discussion about periods, safer sex, and contraception.

BOX 5.3: SPECIFIC QUESTIONS IN A SEXUAL HISTORY

• Are you sexually active?
• Is your sexual partner of the same or a different gender?
• Is your partner cis- or transgender?
• How many sexual partners have you had in the past 6 months?
• Are you satisfied with your sex life? If not, why?
• Do you have concerns about your sex life? What would you like to change?
• What measures do you take to practice safer sex?
• For those at high risk for HIV: Are you using PrEP?
• Have you ever contracted an STI or worry you have one now?
• Have you experienced problems such as erectile dysfunction, premature ejaculation, or pain during intercourse?
• If sexually active and at risk for unintended pregnancy, are you using contraception? Are you satisfied with your method?
• Have you been vaccinated against HPV?
• During a physical exam, include assessment of hair distribution, genital/breast development, and signs of STIs.

BOX 5.4: NURSING CARE PLANNING BASED ON FAMILY TEACHING: COMMUNICATING GENDER AND SEXUALITY TO CHILDREN

• Use anatomical terms rather than nicknames for body parts to normalize anatomy and facilitate reporting of abuse.
• Discuss gender roles and the home environment to avoid imposing rigid expectations; emphasize that play roles can be flexible and inclusive.
• Address discussing reproduction matter-of-factly and treating menstruation as a normal growth sign.

REPRODUCTIVE DEVELOPMENT

• Reproductive development begins at conception and continues through life.
• INTRAUTERINE DEVELOPMENT:
  • Sex assigned at birth is determined by chromosome information supplied by sperm and ovum at conception.
  • Gonad definitions: gonads produce reproductive cells; ovaries and testes.
  • Weeks 5–8: mesonephric (Wolffian) and paramesonephric (Müllerian) ducts form; testosterone influences differentiation toward male structures; absence of testosterone leads to female differentiation.
  • Oocytes are present in ovaries at formation; puberty initiates maturation.
• PUBERTAL DEVELOPMENT:
  • In chromosomal females, puberty is driven by hypothalamic GnRH release, which stimulates anterior pituitary to release FSH and LH.
  • FSH/LH drive estrogen and androgen production, leading to secondary sex characteristics and gonadal maturation.
  • The triggering mechanism may involve a critical body fat percentage; common onset ages are earlier due to nutrition/obesity trends.
  • In chromosomal males, androgens (testosterone) drive male secondary sex characteristics and spermatogenesis; testosterone rises during puberty (typically 12–14 years).
  • Transgender care considerations: resources exist (e.g., Joint Commission field guide).
• HORMONES AND SECONDARY SEX CHARACTERISTICS:
  • Androgens (testosterone) drive male puberty features: testes growth, facial/body hair, deepening voice, penile growth, height increase, spermatogenesis.
  • Estrogen (from ovaries under FSH/LH) drives uterine/fallopian tube/vaginal development, fat distribution, breast development, and epiphyseal closure.
  • Thelarche = breast development onset; adrenarche = early androgen-driven changes; menarche = first menses.
  • Average age of menarche: $12.4$ years, with a normal range of $9–17$ years.

THE MALE REPRODUCTIVE SYSTEM

• External structures: penis, scrotum (thermoregulation for spermatogenesis).
• Internal structures: epididymis, vas deferens, seminal vesicles, ejaculatory ducts, prostate gland, urethra, bulbourethral glands.
• Scrotum function: regulate testicular temperature via cremasteric muscle; normal testicular temperature is about 1°F cooler than body temperature to optimize spermatogenesis.
• Testes: two ovoid glands; Leydig cells produce testosterone; seminiferous tubules produce sperm; descent occurs late in gestation (weeks 34–38); cryptorchidism increases cancer risk (~4–7x) if not descended.
• Spermatogenesis and hormonal control: GnRH → FSH/LH; FSH drives ABP (androgen-binding protein) and supports spermatogenesis; LH stimulates testosterone production; negative feedback regulates FSH/LH.
• Testicular asymmetry is common; most births have left testis lower; testicular self-examination recommended during adolescence.
• Circumcision: AAP notes benefits (UTI, HIV, STI reduction, some cancer risk), risks (surgical complications, reduced penile sensitivity); decision should consider parental preferences and beliefs.
• Semen production: contributions from prostate (60%), seminal vesicles (30%), epididymis (5%), bulbourethral glands (5%).
• Urethra length ~ $18–20\,\text{cm}$; serves urinary and reproductive tracts.
• QSEN Checkpoint 5.2 and 5.1 revolve around safe, patient-centered, and inclusive education (e.g., vasectomy knowledge, episiotomy risks).

BOX 5.2: QSEN-BASED CHECKPOINTS (PEER-LEVEL TEST QUESTIONS)

• Example: A patient asks about vasectomy; question focuses on the structure involved and clarifies misconceptions about testicular removal.

BOX 5.3: SEXUAL HISTORY QUESTIONS FOR ADOLESCENTS AND ADULTS

• See above under BOX 5.3 for a detailed list (sex activity, partners, gender, number of partners, safety practices, PrEP, HPV vaccination, STI history, sexual satisfaction, changes in libido).

THE FEMALE REPRODUCTIVE SYSTEM

• External structures: vulva (mons veneris, labia majora/minora, vestibule, clitoris, fourchette, perineal body, hymen), Skene glands, Bartholin glands, and the external clitoral anatomy (clitoral glans and crura).
• Internal structures: ovaries, fallopian tubes, uterus, vagina.
• Ovaries: ~$3\,\text{cm}$ long, ~$2\,\text{cm}$ wide; produce ova and sex hormones (estrogen, progesterone).
• Fallopian tubes: ~$10\,\text{cm}$ long; divisions include interstitial, isthmus, ampulla (fertilization typically occurs here), infundibulum with fimbriae; lined with mucosa, ciliated cells, and secretory cells; peristalsis helps transport ovum.
• Uterus: hollow, muscular, pear-shaped; layers: endometrium (mucous membrane), myometrium (muscle), perimetrium (outer connective tissue); function includes implantation, fetal protection, labor contractions, and postpartum hemostasis.
• Cervix: canal between internal and external os; endocervical mucus changes with cycle; mucus acts to lubricate and aid sperm passage; high estrogen → thin, elastic mucus; low estrogen → thick, scant mucus; mucus acts as a barrier during non-ovulatory phases.
• Uterine blood supply: ovarian and uterine arteries (from the aorta); uterine veins drain into internal iliac system; the proximity of ureters to uterine structures is clinically important during surgeries (e.g., tubal ligation, cesarean birth, hysterectomy).
• Nerve supply: uterus receives efferent (T5–T10) and afferent (T11–T12 via hypogastric plexus) innervation; pain management approaches (epidural/spinal) target T11–T12 without abolishing contractions.
• Uterine supports: broad ligaments, round ligaments, fascia, and muscle; strong support allows growth during pregnancy but may contribute to prolapse after pregnancy (cystocele, rectocele) if ligaments overstretch.
• Pelvic prolapse:
  • Cystocele: bladder herniation into anterior vaginal wall.
  • Rectocele: rectal herniation into posterior vaginal wall.
• Douglas cul-de-sac: peritoneal space behind uterus; site of fluid/blood accumulation in trauma or ectopic pregnancy; access via culdoscopy or laparoscopy.
• Ligaments: broad ligaments (front/back of uterus), round ligaments (support uterus into inguinal canal).
• Uterine deviations: can be bicornuate, septate, or other unusual shapes; may affect fertility and pregnancy outcomes.
• Vagina:
  • Structure: muscular, mucosal canal from cervix to external vulva; fornices around cervix (posterior/anterior/lateral);
  • Function: birth canal and site of sexual activity; mucosa is stratified squamous; rich vascular supply increases healing potential but bleeding risk during childbirth;
  • Vulvar glands: Skene and Bartholin glands lubricate and aid pH balance; potential infections cause tenderness and discharge; hymen can be perforate or imperforate with clinical implications.
• The vagina's pH is acidic due to lactobacilli metabolism of glycogen in the lining; avoid douches to preserve natural flora; normal pH helps deter pathogens.
• Breasts: mammary glands form during intrauterine life; estrogen stimulates growth at puberty; breast tissue expands during pregnancy; lactation physiology involves oxytocin-driven let-down reflex; Montgomery glands on the areola; breast tissue distribution does not determine breastfeeding ability.
• Menstruation: cycle is a periodic uterine bleed driven by hormonal interplay; average cycle length $28$ days, with a range of $23–35$ days; menses lasts $4–6$ days (range $2–9$ days); typical blood loss ~$30–80$ mL; iron loss around $11$ mg per cycle; menarche average $12.4$ years; variability in timing is normal.
• The four phases of the menstrual cycle:
  • Proliferative (follicular): endometrium thickens with estrogen; days roughly 1–14.
  • Secretory (luteal): progesterone from the corpus luteum causes secretory changes and glycogen-rich environment; days roughly 14–28.
  • Ischemic (late luteal): if fertilization does not occur, corpus luteum regresses; progesterone declines; endometrium degenerates.
  • Menses: shedding of endometrium; day 1 marks a new cycle.
• Ovulation timing: typically around day $14$ in a standard $28$-day cycle, but actual ovulation occurs $14$ days before the end of the cycle; thus, ovulation day = Cycle length − 14. If cycle length is shorter or longer, ovulation shifts accordingly (e.g., 20-day cycle → day 6; 44-day cycle → day 30).
• Graafian (mature) follicle and corpus luteum: LH surge around day $14$ triggers ovulation; after ovulation, the follicle becomes corpus luteum, producing progesterone; if no pregnancy, corpus luteum degenerates to corpus albicans; hormone dynamics are depicted in Fig. 5.12A.
• Cervical mucus changes: estrogen → thin, stretchy mucus around ovulation (spinnbarkeit); progesterone dominance later thickens mucus again; mucus ferning (fern test) indicates high estrogen levels and impending ovulation; spinnbarkeit testing demonstrates mucus stretch.
• Cervical changes: cervix becomes softer and os slightly opens during ovulation; cervical mucus analysis guides natural family planning (NFP).

BOX 5.5: NURSING CARE PLANNING: AN INTERPROFESSIONAL CARE MAP FOR A COUPLE NEEDING SEXUAL COUNSELING

• Case summary: S.M. and K.M. face pregnancy-related sexual concerns; multiple disciplines (nursing, physician, other care team) collaborate.
• Care map includes:
  • Psychosocial assessment of sexuality and pregnancy planning
  • Nursing diagnosis: altered sexuality pattern related to pregnancy and fear of harming fetus
  • Outcome criteria: couple understands coitus is not harmful in a healthy pregnancy; engage in sexual activity or pleasurable noncoital sexual activities as desired
  • Interventions across team roles: nursing education, physician assessment, safety checks, and patient-centered care planning

SEXUAL HEALTH AND THE SEXUAL RESPONSE CYCLE

• Masters and Johnson model (1966) describes stages: excitement, plateau, orgasm, resolution.
  • Excitement: parasympathetic activation, vasodilation, vasocongestion; clitoris and vagina changes in females; erection in males; increased HR/BP/RR.
  • Plateau: maximal genital congestion; clitoral movement; increased nipple elevation; penile erection persists.
  • Orgasm: pelvic muscle contractions; ejaculation (in males) and clitoral/vaginal contractions (in females); intense pleasurable sensation.
  • Resolution: return to unaroused state; males have a refractory period; females may have ability for multiple orgasms.
• The menstrual cycle can influence sexual response: luteal phase tends to increase pelvic vasocongestion and may increase libido; pregnancy can alter sexual response with persistent vasculature changes.
• Myths and safety considerations: avoid misconceptions about orgasm causing miscarriage in pregnancy; discuss expectations and comfort; open communication supports intimate relationships during pregnancy.
• Box 5.5 maps nursing care around couple counseling and sexual health during pregnancy (interprofessional care plan).

MASTURBATION, HARASSMENT, VIOLENCE, AND UNIQUE NEEDS

• MASTURBATION: self-stimulation for erotic pleasure; can be mutually enjoyable; reported to be highly satisfying for some partners.
• SEXUAL HARASSMENT AND VIOLENCE: intimate partner violence during pregnancy is a documented risk; harassment can be illegal and harmful; nurses should report and intervene; safety planning is essential.
• UNIQUE NEEDS OR CONCERNS:
  • Individuals with disabilities: sexual health is a right; disabilities may affect erectile function, orgasm, or conception; rehabilitation can include education and adaptive strategies.
  • Hypoactive sexual desire: can be situational or medication-related; stress, pain, chronic disease, obesity, perimenopause; androgenic therapy may help in some cases.
  • Testosterone: a key hormone in sexual desire across sexes; considerations for therapy and safety.

KEY POINTS FOR REVIEW

• Reproductive organs develop early intrauterine life; puberty marks full function in the reproductive system.
• Chromosomal female internal organs: ovaries, fallopian tubes, uterus, vagina.
• Chromosomal female external organs: mons veneris, labia majora/minora, vestibule, clitoris, fourchette, perineal body, hymen, Skene and Bartholin glands.
• Chromosomal male external structures: penis, scrotum; internal organs: epididymis, vas deferens, seminal vesicles, ejaculatory ducts, prostate, urethra, bulbourethral glands.
• Menstrual cycle: a hormonally driven process that coordinates ovulation and endometrial changes; menarche and menopause mark reproductive milestones.
• Masters and Johnson model of sexual response informs patient education and counseling.
• Education about reproductive function is a primary health strategy, including vulvar/testicular self-exams.
• Reproductive/sexual health assessments should consider family context to plan care that aligns with QSEN competencies and family needs.

CRITICAL THINKING CARE STUDY

• Case: J.R. (hypothetical patient): fertility concerns; weight loss and potential Plan B use implicated; consider work-related risk factors and education on contraception and ovulation; discuss Plan B risks/benefits and fertility timing.

REFERENCES AND RESOURCE CONTEXT

• Authors and institutions cited throughout (AAP, CDC, Joint Commission, etc.).
• Foundational texts on reproductive anatomy and physiology (Edmonds; Tortora & Derrickson; Huether & McCance; Chou et al.; Ledger; Klein et al.).
• Key guidelines on circumcision, pregnancy care, LGBTQ+ health, and reproductive technologies.

FIGURE AND BOX REFERENCES (MENTIONED)

• Fig. 5.1: Male internal and external reproductive organs
• Fig. 5.2: Circumcised vs. uncircumcised penis
• Fig. 5.3: Female external genitalia (vulva)
• Fig. 5.4: Chromosomal female internal organs
• Fig. 5.5: Fallopian tube anatomy
• Fig. 5.6: Blood supply to the uterus
• Fig. 5.7: Cystocele and rectocele diagrams
• Figure 5.11: Uterine innervation and pain control (epidural/spinal)
• Figure 5.12A/B: Hormonal/plasma concentrations and ovarian/uterine changes during the cycle
• Fig. 5.13: Fern pattern in mucus; Fig. 5.14: Spinnbarkeit

SUMMARY OF NUMERICAL AND FORMULA-BASED CONTENT

• HPV vaccination status assessment for individuals aged 9–45.
• Menstrual cycle metrics:
  • Cycle length: $ext{avg } 28 ext{ days} ext{ (range } 23–35 ext{ days)}$
  • Menses duration: $4 ext{–}6 ext{ days (range } 2 ext{–}9)$
  • Blood loss: $ext{avg } 30 ext{–}80 ext{ mL}$ per cycle
  • Iron loss: $ext{approx. } 11 ext{ mg}$ per cycle
• Ovulation timing rule: $ext{Ovulation day} = ext{Cycle length} - 14$; for a 28-day cycle, day $14$; shorter/longer cycles shift accordingly.
• Endometrial phases timings:
  • Proliferative (days 1–14 roughly) with estrogen-driven thickening
  • Secretory (days 14–28) with progesterone-driven secretory changes
  • Ischemic (late luteal) and Menses (start of new cycle)
• Sperm production timing and maturation: epididymal maturation ~$12 ext{–}20 ext{ days}$; total maturation to full maturity ~$65 ext{–}75 ext{ days}$ post-spermatogenesis initiation
• Semen composition: prostate $60\%$, seminal vesicles $30\%$, epididymis $5\%$, bulbourethral glands $5\%$
• Testicular descent affects cancer risk if undescended: cryptorchidism increases cancer risk; descent typically occurs in late gestation.
• Hormonal feedback: testosterone/estrogen influence GnRH and FSH/LH levels via negative feedback loops.

REMEMBER

• Reproductive health education should be inclusive and culturally sensitive.
• Sexual health literacy improves patient outcomes across all settings; nurses are pivotal in promoting understanding, safety, and informed decision-making.